Literature DB >> 12099655

Radiation therapy for high grade soft tissue sarcomas of the extremities treated with limb-preserving surgery.

C P Karakousis1, G C Zografos.   

Abstract

AIM: It is common to use either pre- or post-operative radiation for high grade sarcomas undergoing limb-conserving surgery. Since 1977, we have adopted a selective policy of post-operative radiation, given only in patients with inadequate surgical margins.
METHODS: A retrospective review of 114 patients (1977-1995) with high grade adult soft tissue sarcomas of the extremities was carried out. Amputation was required in 10 (9%). Patients with a minimum surgical margin <2 cm (n=33) received adjuvant radiation (29%).
RESULTS: No complications occurred in 81/114. Wound complications were infection (14%), seroma (6%), haematoma (4%), dehiscence (4%) and skin edge necrosis (2%). Remedial operations were required in four (3%). Overall, the local recurrence rate was 23/114. Patients with surgery only (n=57) or surgery plus systemic chemotherapy (n=24) manifested local recurrence in 15/81 (19%) and those with surgery plus radiation (n=21) or surgery and radiation and chemotherapy (n=12) suffered local recurrence in 8/33. The local recurrence rate for tumours < or =5 cm was 6/32 and for those >5 cm 17/82, P=1.0. The 5 year survival rate was 60% for tumours < or =5 cm (n=32) and 46% for tumours > or =5 cm (n=82) (P=0.009).
CONCLUSIONS: (1) Limb preservation was feasible in 91% of patients. (2) When the local treatment modality was surgery alone ('wide' margins) the local recurrence rate was 19%, and when it was surgery plus radiation (narrow margins) it was 24%. (3) Selective use of radiation (in patients with narrow margins) and reliance on surgery alone in cases amenable to wide resection may be a legitimate alternative to universal application of radiation with conservative resection. Copyright 2002 Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12099655     DOI: 10.1053/ejso.2002.1264

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  12 in total

Review 1.  Recent advances in radiotherapy for soft-tissue sarcoma.

Authors:  Brian O'Sullivan; Iain Ward; Charles Catton
Journal:  Curr Oncol Rep       Date:  2003-07       Impact factor: 5.075

Review 2.  Therapeutic options and postoperative wound complications after extremity soft tissue sarcoma resection and postoperative external beam radiotherapy.

Authors:  Mohamed H Abouarab; Iman L Salem; Magdy M Degheidy; Dominic Henn; Christoph Hirche; Ahmad Eweida; Matthias Uhl; Ulrich Kneser; Thomas Kremer
Journal:  Int Wound J       Date:  2017-12-05       Impact factor: 3.315

3.  A new modification of combining vacuum therapy and brachytherapy in large subfascial soft -tissue sarcomas of the extremities.

Authors:  Maximilian Rudert; Cornelia Winkler; Boris Michael Holzapfel; Hans Rechl; Peter Kneschaurek; Reiner Gradinger; Michael Molls; Barbara Röper
Journal:  Strahlenther Onkol       Date:  2010-03-26       Impact factor: 3.621

4.  Beta-catenin is a mediator of the response of fibroblasts to irradiation.

Authors:  Ananta Gurung; Faisal Uddin; Richard P Hill; Peter C Ferguson; Benjamin A Alman
Journal:  Am J Pathol       Date:  2008-11-26       Impact factor: 4.307

5.  Surgical margins and handling of soft-tissue sarcoma in extremities: a clinical practice guideline.

Authors:  R Kandel; N Coakley; J Werier; J Engel; M Ghert; S Verma
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

Review 6.  Adjuvant therapy for extremity sarcomas.

Authors:  Michael Schlieman; Richard Smith; William G Kraybill
Journal:  Curr Treat Options Oncol       Date:  2006-11

Review 7.  Primary multidisciplinary management of extremity soft tissue sarcomas.

Authors:  Paul Clarkson; Peter C Ferguson
Journal:  Curr Treat Options Oncol       Date:  2004-12

8.  Radiotherapy for soft tissue sarcoma of the proximal lower extremity.

Authors:  Brendan Prendergast; John B Fiveash; C Parker Gibbs; Mark T Scarborough; Daniel J Indelicato
Journal:  Sarcoma       Date:  2010-10-14

9.  Phase I/II and phase II studies of targeted gene delivery in vivo: intravenous Rexin-G for chemotherapy-resistant sarcoma and osteosarcoma.

Authors:  Sant P Chawla; Victoria S Chua; Lita Fernandez; Doris Quon; Andreh Saralou; William C Blackwelder; Frederick L Hall; Erlinda M Gordon
Journal:  Mol Ther       Date:  2009-06-16       Impact factor: 11.454

Review 10.  Reconstruction for lower extremity limb salvage in soft tissue carcinoma.

Authors:  Neal S Topham
Journal:  Curr Treat Options Oncol       Date:  2003-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.